New evidence from a Chinese cohort presented today at the European Lung Cancer Congress (ELCC) 2026 shows that onetime ‑lowdose computed tomography (LDCT) screening can significantly reduce lung cancer mortality in a non–risk‑ based population, including individuals with no smoking history.
